This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMicroRNA in disease regulation · RNA Interference and Gene Delivery · RNA Research and Splicing
After this article [1] was published, concerns were raised about Figures 1–3.
Specifically:
The authors did not respond to queries about these concerns. In the absence of underlying data, the above issues remain unresolved.
In light of the above concerns, which call into question the integrity and reliability of these data, the PLOS One Editors retract this article.
All authors either did not respond directly or could not be reached.
Owing to the concerns about similarities with previously published content [2], published in 2013 by Elsevier, which is not offered under a CC BY license, the MDA-MB-231/sh panel of Figure 2A is therefore excluded from this article’s [1] license. At the time of retraction, the article [1] was republished to note this exclusion in the Figure 2 legend and the article’s copyright statement. Please refer to [2] for the correct copyright for this panel.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Yin J, Zheng G, Jia X, Zhang Z, Zhang W, Song Y, et al. A Bmi 1-mi RN As cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells. P Lo S One. 2013;8(9):e 73268. doi: 10.1371/journal.pone.0073268 24039897 PMC 3767789 · doi ↗ · pubmed ↗
- 2Tang H, Kong Y, Guo J, Tang Y, Xie X, Yang L, et al. Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of mi R-200b and mi R-22. Cancer Lett. 2013;340(1):72–81. doi: 10.1016/j.canlet.2013.06.027 23851184 · doi ↗ · pubmed ↗